Yuri Deigin, MBA
Yuri Deigin, MBA is a serial biotech entrepreneur, longevity research evangelist and activist, and a cryonics advocate. He is an expert in drug development and venture investments in biotechnology and pharmaceuticals. He is currently leading YouthBio Therapeutics which is developing gene therapies that harness the rejuvenating power of partial cellular reprogramming with Yamanaka factors in order to combat Alzheimer’s and other brain diseases.
His life goal is to do everything possible to minimize human suffering from various diseases, especially terminal age-related diseases such as cancer, Alzheimer’s, and cardiovascular disease and to help humanity eradicate them.
As an activist, blogger, and speaker, he is conveying the magnitude of human suffering these diseases cause, as they take over 100,000 lives each day. As a biotech entrepreneur, Yuri is doing his modest part by putting together projects that could yield such therapies. He believes that one day humanity will cure all such diseases, and he wants to do whatever he can to hasten that day.
Yuri earned his MBA from the Columbia Business School at Columbia University in 2010, where he became a specialist in the development and marketing of new drugs. He earned his Bachelor’s degree in Science in the fields of Computer Science and Mathematics in 2001 from the University of Toronto.
Yuri has a wide range of interests: a passion for coding, complexity theory and quantum computation, physics, space exploration, and also an interest in finance, economics, and the stock market. He has been trading and investing since he was 19. His investing philosophy has undergone a significant transformation over the years; today he subscribes to the value investing approach, originally taught by Graham and Dodd at Columbia Business School and later made famous by its most successful adherents Warren Buffett and Charlie Munger.
Visit his LinkedIn profile and his company’s webpage. Read his blog at Medium or follow him on Twitter.